Trial record 1 of 1 for:    CALGB 50303
Previous Study | Return to List | Next Study

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00118209
Recruitment Status : Active, not recruiting
First Posted : July 11, 2005
Last Update Posted : July 10, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : October 2017
  Study Completion Date : No date given